[Moyamoya disease]

P Papanagiotou1, I Q Grunwald, M Politi

  • 1Klinik für Diagnostische und Interventionelle Neuroradiologie, Universitätsklinikum des Saarlandes Homburg/Saar. panagiotis_papanagiotou@hotmail.com

Der Radiologe
|May 3, 2005
PubMed

Insights

Moyamoya disease is a rare condition causing progressive narrowing of brain arteries. This review covers its clinical signs, imaging, and characteristic "puff of smoke" angiographic appearance.

Area of Science:

  • Neurology
  • Vascular Medicine
  • Radiology

Background:

  • Moyamoya disease is an idiopathic progressive vasculopathy.
  • Characterized by progressive narrowing of the distal internal carotid artery and proximal circle of Willis.
  • Collateral vessels form to compensate for stenosis, creating a characteristic angiographic appearance.

Purpose of the Study:

  • To review the clinical manifestations of Moyamoya disease.
  • To discuss the key imaging findings associated with the condition.
  • To describe the distinct angiographic features of Moyamoya disease.

Main Methods:

  • Literature review of Moyamoya disease.
  • Analysis of clinical presentation data.
  • Evaluation of diagnostic imaging and angiography.

Main Results:

  • Moyamoya disease presents with progressive stenosis of major cerebral arteries.
  • Characteristic collateral vessels form, appearing as a 'puff of smoke' on angiography.
  • Clinical symptoms vary, often related to ischemic events or hemorrhage.

Conclusions:

  • Moyamoya disease requires accurate diagnosis through clinical, imaging, and angiographic evaluation.
  • Understanding its features is crucial for appropriate patient management.
  • This review provides a comprehensive overview for clinicians and researchers.

Related Concept Videos

Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...